AXNX
Axonics, Inc.
Total Trades
93
Buys
0
Sells
49
Largest Trade
N/A
Insiders
9
Institutional Funds
1
Inst. Value
$1K–$15K
Activist Filings
8
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Keese Kari Leigh | CFO | SELL | $100K–$500K | 3K | $69.41 | Oct 3, 2024 |
| Noblett Karen | Chief Medical Offi… | EXERCISE | N/A | 28K | — | Feb 2, 2024 |
| Noblett Karen | Chief Medical Offi… | SELL | $500K+ | 11K | $67.74 | Feb 2, 2024 |
| Woock John | EVP | SELL | $1M+ | 16K | $67.74 | Feb 2, 2024 |
| Woock John | EVP | EXERCISE | N/A | 28K | — | Feb 2, 2024 |
| Ford Alfred J Jr | Chief Commercial O… | SELL | $1M+ | 17K | $67.74 | Feb 2, 2024 |
| Ford Alfred J Jr | Chief Commercial O… | EXERCISE | N/A | 26K | — | Feb 2, 2024 |
| Keese Kari Leigh | CFO | EXERCISE | N/A | 6K | — | Feb 2, 2024 |
| Keese Kari Leigh | CFO | SELL | $100K–$500K | 3K | $67.74 | Feb 2, 2024 |
| COHEN RAYMOND W | CEO | SELL | $1M+ | 35K | $67.74 | Feb 2, 2024 |
| COHEN RAYMOND W | CEO | EXERCISE | N/A | 63K | — | Feb 2, 2024 |
| Noblett Karen | Chief Medical Offi… | SELL | $500K+ | 8K | $63.25 | Dec 29, 2023 |
| Dearen Danny L. | President & CFO | EXERCISE | N/A | 11K | — | Oct 3, 2023 |
| Dearen Danny L. | President & CFO | SELL | $100K–$500K | 8K | $56.87 | Oct 3, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | SELL | $500K+ | 15K | $62.34 | Aug 17, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | SELL | $50K–$100K | 2K | $62.01 | Aug 2, 2023 |
| Dearen Danny L. | President & CFO | SELL | $100K–$500K | 8K | $49.46 | Jun 1, 2023 |
| Dearen Danny L. | President & CFO | EXERCISE | $100K–$500K | 13K | $14.19 | Apr 26, 2023 |
| Dearen Danny L. | President & CFO | SELL | $1M+ | 20K | $60.21 | Apr 26, 2023 |
| Dearen Danny L. | President & CFO | SELL | $100K–$500K | 2K | $60.01 | Apr 25, 2023 |
| Dearen Danny L. | President & CFO | EXERCISE | $15K–$50K | 2K | $14.19 | Apr 25, 2023 |
| Dearen Danny L. | President & CFO | EXERCISE | $100K–$500K | 15K | $16.00 | Apr 5, 2023 |
| Dearen Danny L. | President & CFO | SELL | $500K+ | 15K | $55.27 | Apr 5, 2023 |
| Sama Rinda | COO | SELL | $1M+ | 23K | $56.31 | Feb 24, 2023 |
| Sama Rinda | COO | EXERCISE | N/A | 31K | — | Feb 3, 2023 |
| Sama Rinda | COO | SELL | $1M+ | 19K | $61.09 | Feb 3, 2023 |
| Sama Rinda | COO | GRANT | N/A | 9K | — | Feb 3, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | SELL | $500K+ | 10K | $61.07 | Feb 3, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | EXERCISE | N/A | 17K | — | Feb 3, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | GRANT | N/A | 8K | — | Feb 3, 2023 |
| Dearen Danny L. | President & CFO | GRANT | N/A | 5K | — | Feb 3, 2023 |
| Dearen Danny L. | President & CFO | SELL | $500K+ | 14K | $61.10 | Feb 3, 2023 |
| Dearen Danny L. | President & CFO | EXERCISE | N/A | 25K | — | Feb 3, 2023 |
| COHEN RAYMOND W | CEO | SELL | $1M+ | 31K | $61.09 | Feb 3, 2023 |
| COHEN RAYMOND W | CEO | GRANT | N/A | 21K | — | Feb 3, 2023 |
| COHEN RAYMOND W | CEO | EXERCISE | N/A | 62K | — | Feb 3, 2023 |
| Noblett Karen | Chief Medical Offi… | GRANT | N/A | 5K | — | Feb 3, 2023 |
| Noblett Karen | Chief Medical Offi… | SELL | $100K–$500K | 5K | $61.11 | Feb 3, 2023 |
| Noblett Karen | Chief Medical Offi… | EXERCISE | N/A | 10K | — | Feb 3, 2023 |
| Woock John | EVP | SELL | $500K+ | 12K | $61.07 | Feb 3, 2023 |
| Woock John | EVP | EXERCISE | N/A | 22K | — | Feb 3, 2023 |
| Woock John | EVP | GRANT | N/A | 9K | — | Feb 3, 2023 |
| Woock John | EVP | SELL | $1M+ | 30K | $67.34 | Jan 20, 2023 |
| Woock John | EVP | EXERCISE | $500K+ | 30K | $17.48 | Jan 20, 2023 |
| COHEN RAYMOND W | CEO | SELL | $1M+ | 41K | $65.94 | Jan 19, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | EXERCISE | $100K–$500K | 36K | $13.52 | Jan 19, 2023 |
| Ford Alfred J Jr | Chief Commercial O… | SELL | $1M+ | 36K | $66.40 | Jan 19, 2023 |
| Lopez Esteban | Director | SELL | $100K–$500K | 2K | $67.42 | Dec 16, 2022 |
| Noblett Karen | Chief Medical Offi… | SELL | $1M+ | 32K | $78.16 | Sep 21, 2022 |
| Noblett Karen | Chief Medical Offi… | EXERCISE | $500K+ | 32K | $19.19 | Sep 21, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2024 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Blue Trust, Inc. | 71 | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
10.4%
5.3M shares
SC 13G/A · Feb 12, 2024
2.3%
1.2M shares
SC 13G/A · Jan 25, 2024
8.3%
4.2M shares
SC 13G/A · Dec 11, 2023
10.9%
5.5M shares
The Vanguard Group - 23-1945930
SC 13G/A · Mar 10, 2023
10.3%
5.1M shares
SC 13G/A · Jan 31, 2023
7.3%
3.6M shares
Cooperatieve Gilde Healthcare IV U.A.
SC 13G/A · Jun 6, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
4.9%
2.3M shares